Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Language
Year range
1.
An. bras. dermatol ; 96(5): 595-597, Sept.-Oct. 2021. graf
Article in English | LILACS | ID: biblio-1345137

ABSTRACT

Abstract Trichosporon asahii is the causal agent of trichosporonosis. Patients with immunosuppression or hematological malignancies are at higher risk of infection. Skin and mucosal involvement appear as fast-growing papulonodular lesions and necrotic ulcers. Internal organ dissemination is lethal. Therapeutic success depends on the underlying disease. Here, the authors present the first case of disseminated mucocutaneous trichosporonosis in a patient with a post-mortem diagnosis of histiocytic sarcoma, a rare and aggressive haematolymphoid neoplasm. Regretfully, death occurred despite treatment with liposomal amphotericin B and supportive measures, showcasing the fatality of both diseases.


Subject(s)
Humans , Trichosporon , Histiocytic Sarcoma/drug therapy , Trichosporonosis/diagnosis , Trichosporonosis/drug therapy , Basidiomycota , Antifungal Agents/therapeutic use
2.
Arq. bras. oftalmol ; 78(4): 252-254, July-Aug. 2015. ilus
Article in English | LILACS | ID: lil-759251

ABSTRACT

ABSTRACTPostoperative fungal endophthalmitis is a rare but devastating complication of cataract surgery. Vitrectomy and intravitreal amphotericin B injection as well as administration of systemic antifungal agents have been suggested as optimal treatments for fungal endophthalmitis. However, this therapy may fail to eliminate fungal species resistant to current antifungal agents. The saprophytic fungus Trichosporon asahii is frequently observed as a cause of endogenous endophthalmitis in immunosuppressed patients. We report a case of postoperative endophthalmitis caused by T. asahii, resistant to amphotericin B. To the best of our knowledge, this is the first report of T. asahii endophthalmitis successfully treated with intravitreal and systemic voriconazole, pars plana vitrectomy, and removal of the intraocular lens and entire lens capsule.


RESUMOEndoftalmite fúngica pós-operatória é uma complicação rara mas devastadora da cirurgia de catarata. A vitrectomia e injeção intravítrea de anfotericina B, bem como agentes fungicidas sistêmicos, têm sido sugeridos como tratamentos ideais para endoftalmite fúngica. No entanto, esta terapia pode falhar em erradicar as espécies de fungos resistentes aos agentes antifúngicos atuais. Uma dessas espécies de fungos é o fungo saprófita,Trichosporon asahii, que é frequentemente observada, como causa de endoftalmite endógena, em pacientes imunodeprimidos. Relatamos um caso de endoftalmite pós-operatória causada porT. asahii que é resistente a anfotericina B. Ao nosso conhecimento, este é o primeiro relato de endoftalmite porT. asahii tratado com sucesso com voriconazol intravítreo e sistêmico, vitrectomia viapars plana, e remoção da lente intraocular e saco capsular.


Subject(s)
Aged , Humans , Male , Antifungal Agents/administration & dosage , Cataract Extraction/adverse effects , Endophthalmitis/drug therapy , Eye Infections, Fungal/drug therapy , Trichosporonosis/drug therapy , Voriconazole/administration & dosage , Endophthalmitis/microbiology , Eye Infections, Fungal/microbiology , Intravitreal Injections , Trichosporon/classification , Trichosporon/isolation & purification
3.
Rev. Inst. Med. Trop. Säo Paulo ; 54(1): 1-3, Jan.-Feb. 2012.
Article in English | LILACS | ID: lil-614888

ABSTRACT

Trichosporon spp. are yeasts capable of causing invasive disease, which mainly affect immunocompromised patients. A clinical strain of T. asahii was isolated from the blood cultures of patients admitted to the General Hospital of Fortaleza. Susceptibility tests were conducted by disk diffusion and broth microdilution. The isolated strain of T. asahii was resistant to fluconazole. The patient used amphotericin B and caspofungin in order to facilitate the microbiological cure. It was the first isolation and identification of T. asahii in blood culture in Ceará, Brazil.


Trichosporon spp. são leveduras capazes de causar doença invasiva, que afetam principalmente pacientes imunocomprometidos. Uma cepa clínica de T. asahii foi isolada em hemocultura de paciente internado no Hospital Geral de Fortaleza. Os testes de suscetibilidade foram realizados por difusão em disco e microdiluição em caldo. A cepa isolada do T. asahii foi resistente ao fluconazol, o paciente fez uso de anfotericina B e caspofungina então a cura microbiológica ocorreu. Foi o primeiro isolamento e identificação de T. asahii em hemocultura no Ceará, Brasil.


Subject(s)
Adult , Humans , Male , Amphotericin B/pharmacology , Antifungal Agents/pharmacology , Cross Infection/microbiology , Fluconazole/pharmacology , Trichosporon/drug effects , Trichosporonosis/microbiology , Immunocompromised Host , Microbial Sensitivity Tests , Trichosporon/isolation & purification , Trichosporonosis/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL